A previous study showed that PLCG2 had high expression in small cell lung cancer (SCLC) and was associated with increased stem-like and pro-metastatic potential and reduced overall survival in patients [26, 31], so we suspected that PLCG2 plays an oncogenic role in NSCLC. This evidence concerns the gene PLCG2 and non-small cell lung carcinoma.